Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe79f6eb1e709dbf956eaeaccc1c540 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2014-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3906217f45a1f76bb53f0f52e9bf5fb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_890f9ab63548b2943eac281aa0aa7e1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be8af2745d092d74d93629b815ebba2 |
publicationDate |
2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014202667-B2 |
titleOfInvention |
Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
abstract |
A method for treating fodate receptoriapha-positive ovarian cancer irn a subject in need of treatment of said cancer includes administering to the subject a therapeuticaly effective amount of an antibody that specifically binds folate receptor-alpha, wherein said antibody is produced by ces having American Type CAlture Colection accession number PTA-7552, |
priorityDate |
2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |